Puma Biotechnology, Inc. (PBYI)
7.31
+0.04
(+0.55%)
USD |
NASDAQ |
May 27, 16:00
7.31
0.00 (0.00%)
After-Hours: 18:39
Puma Biotechnology Cash from Investing (Quarterly) : 2.474M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 0.00 |
| AbbVie, Inc. | -574.00M |
| Agios Pharmaceuticals, Inc. | 141.31M |
| Editas Medicine, Inc. | 0.064M |
| ACADIA Pharmaceuticals, Inc. | 66.28M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 15.42M |
| Cash from Financing (Quarterly) | -11.33M |
| Free Cash Flow | 53.60M |
| Free Cash Flow Per Share (Quarterly) | 0.3032 |
| Free Cash Flow to Equity (Quarterly) | 28.01M |
| Free Cash Flow to Firm (Quarterly) | 16.22M |
| Free Cash Flow Yield | 14.42% |